nimbin has been researched along with Liver Diseases, Alcoholic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almutairi, BO; Almutairi, MH; Arockiaraj, J; Gopinath, P; Guru, A; Haridevamuthu, B; Juliet, A; Murugan, R; Prathap, P; Sudhakaran, G | 1 |
1 other study(ies) available for nimbin and Liver Diseases, Alcoholic
| Article | Year |
|---|---|
Reverse pharmacology of Nimbin-N2 attenuates alcoholic liver injury and promotes the hepatoprotective dual role of improving lipid metabolism and downregulating the levels of inflammatory cytokines in zebrafish larval model.
Topics: Animals; Anti-Inflammatory Agents; Cyclooxygenase 2; Cytokines; Ethanol; Inflammation; Interleukin-10; Larva; Limonins; Lipid Metabolism; Lipids; Liver; Liver Diseases, Alcoholic; Oxidative Stress; Reactive Oxygen Species; RNA, Messenger; Tumor Necrosis Factor-alpha; Zebrafish | 2022 |